Login

The pandemic accelerated our focus on operational resilience and digital transformation. 00:10:00

Share On Facebook Share On Twitter

Doron Blachar is Chief Executive Officer, Ormat Technologies Inc.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:00:00
Therapeutic Innovation - Steven A. McCarroll, Ph.D. Dorothy and Milton Flier Professor of Biomedical Science and Genetics, HMS
00:10:00
Transatlantic Gains: How Lucerne Fund Leveraged European Growth for Record Returns | Mark Whelan - Fund Manager, Lucerne Capital Management
00:10:00
Capella Minerals CEO Mary Kroth Discusses Strategic Gold and Copper Projects in Canada and Scandinavia, Upcoming Milestones, and Team Strength at Mining Conference
00:10:00
Colonialism: A Moral Reassessment|Nigel Biggar,Professor,Oxford University
00:10:00
BizLink elocab Why it’s Cool to Work at BizLink elocab | Felix Teng, CEO, BizLink Holding Inc3665:TAI
00:10:00
DCC CEO Donal Murphy at SEI Awards Celebration 2019 | Donal Murphy - CEO of DCC plc
00:10:00
Mike Neus Discusses Sharing Form PF Data with Investors
00:10:00
Fabricio Mitre Discusses the MITRE Group’s Agricultural Legacy and Growth | Fabrício Mitre, CEO , Mitre Realty Empreendimentos e Participações SA.
00:10:00
So what we do:Investors should move to higher ground|Steve Jang,founder,Kindred Ventures
00:10:00
Introducing YESCan: Streamlining Fenestration Product Data Submission to NRCan | Valmor Ruscheck - CEO of Natural Resources Canada
00:10:00
Kefi Minerals Gears Up for Development in Ethiopia and Saudi Arabia
00:00:00
Michael A. Martino, Chief Executive Officer, Ampio Pharmaceuticals Inc

© 2026 Nehu